COMMUNIQUÉS West-GlobeNewswire

Cansortium: Multi-State Cannabis Operator Trading on CSE -- CFN Media
02/04/2019
SEATTLE, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication [...]
Jounce Therapeutics Reports Improved PFS and OS Associated with Vopratelimab (JTX-2011) Treatment Emergent Biomarker at the 2019 American Association for Cancer Research (AACR) Annual Meeting
02/04/2019
- Improved PFS and OS observed in patients treated with vopratelimab who have emergence of ICOS hi CD4 T cells compared to patients with ICOS lo CD4 T cells - - ICOS hi CD4 T cells demonstrate distinct, activated T [...]
Genocea Presents Data at AACR 2019 Supporting Utility of ATLAS™ Platform in Predicting Melanoma Patient Response to Immune Checkpoint Inhibitors
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing neoantigen cancer immunotherapies, today announced the presentation of data from [...]
Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFβ1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy
02/04/2019
Preclinical data presented at the American Association for Cancer Research annual meeting provide further support for the potential of SRK-181 to overcome primary resistance to checkpoint blockade therapy (CBT) TGFβ1- [...]
Dynavax Presents Phase 1b Data on Inhaled DV281 TLR9 Agonist at the 2019 AACR Annual Meeting
02/04/2019
Using an investigational safety treatment regimen, inhaled DV281 in combination with systemic nivolumab was well tolerated in a population of heavily pre-treated NSCLC patients Target engagement was observed at all dose [...]
Maple Leaf Green World Inc. Announces Filing of 2018 Audited Annual Financial Statements and Management Discussion & Analysis and Provides a Corporate Update
02/04/2019
CALGARY, Alberta, April 02, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) has filed its 2018 audited annual financial statements and related [...]
Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pre-clinical in vivo models of lung cancer
02/04/2019
Data presented at AACR Annual Meeting 2019 In vivo study conducted alone or in collaboration with The University of Texas MD Anderson Cancer Center demonstrated: NBTXR3 in combination with a PD-1 inhibitor enhanced an [...]
Efficacité de la combinaison NBTXR3 (premier produit de sa classe), radiothérapie et immunothérapie avec anti-PD-1 démontrée dans le cancer du Poumon résistant dans des modèles précliniques in vivo
02/04/2019
Efficacité de la combinaison NBTXR3 (premier produit de sa classe), radiothérapie et immunothérapie avec anti-PD-1 démontrée dans le cancer du Poumon résistant dans des modèles précliniques in vivo Données présentées au [...]
Molina Healthcare Announces First Quarter 2019 Earnings Release and Conference Call Dates
02/04/2019
LONG BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the first quarter ended March 31, 2019. Molina Healthcare will issue [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
02/04/2019
Company Announcement Copenhagen, Denmark; April 2, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 146,961 shares as a consequence of the exercise of employee warrants. The increase is [...]
SuperSonic Imagine to Highlight Breast Ultrasound Imaging with Aixplorer® MACH 30 at SBI/ACR Breast Imaging Symposium
02/04/2019
Hollywood, Florida, April 4-7, 2019 Visit Supersonic Imagine at Booth # 208 AIX-EN-PROVENCE, France, April 02, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialising in medical [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2019
02/04/2019
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 31 mars 2019
02/04/2019
Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2019
02/04/2019
LYON, France, April 02, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social - 31 Mars 2019
02/04/2019
LYON, France, 02 avr. 2019 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]
OSE Immunotherapeutics Presents New Clinical and Preclinical Data on its Immuno-Oncology Portfolio at AACR 2019
02/04/2019
Oral presentation highlights investigator case reports showing early signs of activity of Tedopi® in patients with non-small cell lung cancer in third-line treatment after checkpoint inhibitor failure Poster [...]
« L’autisme doit devenir une priorité nationale »
02/04/2019
MONTRÉAL, 02 avr. 2019 (GLOBE NEWSWIRE) -- Le taux de prévalence de l’autisme devrait en faire une priorité nationale. En 2018, le taux de prévalence de l’autisme au Canada était de 1 sur 66 et celui du Québec de 1 sur [...]
Chr. Hansen and Lonza establish a 50/50 joint venture to pioneer the emerging market for live biotherapeutic products
02/04/2019
Company Announcement No. 4/2019 Announcement attached below For further information, please contact: Head of Investor Relations Martin Riise Tel.: +45 5339 2250 Investor Relations Officer Annika Stern Tel.: +45 2399 [...]
Amfora Licenses Gene Editing Technology
02/04/2019
SAN FRANCISCO, April 02, 2019 (GLOBE NEWSWIRE) -- Today Amfora, a biotechnology company, announced it has reached a non-exclusive research and commercial license agreement with Corteva Agriscience™, the Agriculture [...]

Pages